Craft
  • Home
  •  / Verve Therapeutics
Verve Therapeutics

Verve Therapeutics

Market Capitalization

$1.7 B

2022-09-19

Verve Therapeutics Summary

Company summary

Overview
Verve Therapeutics is a biotechnology company focused on discovering and developing therapies for heart disease. It develops medicines to edit the genome of adults that mimic naturally occurring gene variants to lower LDL cholesterol and triglyceride levels. Its products can be used for the treatment of coronary artery and cardiovascular diseases.
Type
Public
Founded
2018
HQ
Cambridge, MA, US | view all locations
Website
https://www.vervetx.com
Cybersecurity rating
ESG rating
out of 100 | View all ESG data
Sectors

Key people

  • Burt Adelman

    Burt Adelman, Co-Founder and Chairman of the Board

  • J. Keith Joung
  • Anthony Philippakis

    Anthony Philippakis, Co-Founder, Board Member

  • Sekar Kathiresan

    Sekar Kathiresan, Co-Founder, Chief Executive Officer and Board Member

LocationsView all

1 location detected

  • Cambridge, MA HQ

    United States

    NE47, 500 Technology Square #901

Verve Therapeutics Financials

Summary financials

Footer menu